20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 5,8,11,14-eicosatetraynoic acid in 3 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (5,8,11,14-eicosatetraynoic acid) | Trials (5,8,11,14-eicosatetraynoic acid) | Recent Studies (post-2010) (5,8,11,14-eicosatetraynoic acid) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 573 | 1 | 16 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | 5,8,11,14-eicosatetraynoic acid (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.78 | |
| Myeloid cell leukemia sequence 1 (BCL2-related) | Homo sapiens (human) | 0.4415 | |
| envelope glycoprotein | Human immunodeficiency virus 1 | 11.9 | |
| Vif | Human immunodeficiency virus 1 | 0.86 | |
| Tat | Human immunodeficiency virus 1 | 2.379 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.86 | |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | 21.683 | |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 17.7 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.78 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 1.78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, T; Good, DW; Wang, DH | 1 |
| Hercule, HC; Oyekan, AO | 1 |
| Cloutier, M; Morin, C; Proteau, S; Rousseau, E | 1 |
3 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 5,8,11,14-eicosatetraynoic acid
| Article | Year |
|---|---|
Angiotensin II inhibits HCO-3 absorption via a cytochrome P-450-dependent pathway in MTAL.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Acid-Base Equilibrium; Angiotensin II; Animals; Benzoquinones; Bicarbonates; Cyclic AMP; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Genistein; Hydroxyeicosatetraenoic Acids; Kidney Medulla; Lactams, Macrocyclic; Loop of Henle; Male; Nitric Oxide; Protein Kinase C; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Signal Transduction; Sodium | 1999 |
Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Arterioles; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dansyl Compounds; Endothelin-1; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mixed Function Oxygenases; Oligopeptides; Piperidines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction | 2000 |
Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Bronchi; Calcium; Calcium Channels; Capsaicin; Cyclohexanones; Cytochrome P-450 CYP4A; Female; Guinea Pigs; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Intracellular Membranes; Lipoprotein Lipase; Male; Muscle Contraction; Muscle, Smooth; Protease Inhibitors; Receptors, Drug; Time Factors; Trachea | 2005 |